VENTURA, SELENA
VENTURA, SELENA
CENTRO INTERDIPARTIMENTALE ALMA MATER INSTITUTE ON HEALTHY PLANET
Assegnisti
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy
2018 Mancarella, Caterina; Pasello, Michela; Ventura, Selena; Grilli, Andrea; Calzolari, Linda; Toracchio, Lisa; Lollini, Pier Luigi; Donati, Davide Maria; Picci, Piero; Ferrari, Stefano; Scotlandi, Katia
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression
2014 Marino, M.T.; Grilli, A.; Baricordi, C.; Manara, M.C.; Ventura, S.; Pinca, R.S.; Bellenghi, M.; Calvaruso, M.; Mattia, G.; Donati, D.; Tripodo, C.; Picci, P.; Ferrari, S.; Scotlandi, K.
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy
2012 Nakatani F.; Ferracin M.; Manara M.C.; Ventura S.; del Monaco V.; Ferrari S.; Alberghini M.; Grilli A.; Knuutila S.; Schaefer K.L.; Mattia G.; Negrini M.; Picci P.; Serra M.; Scotlandi K.
NVE-BEZ235 as a new therapeutic option for sarcomas.
2010 M.C. Manara; G. Nicoletti; D. Zambelli; S. Ventura; C. Guerzoni; L. Landuzzi; P.-L. Lollini; S.-M. Maira; C. Garcia-Echeverria; M. Mercuri; P. Picci; K. Scotlandi
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy | Mancarella, Caterina; Pasello, Michela; Ventura, Selena; Grilli, Andrea; Calzolari, Linda; Toracc...hio, Lisa; Lollini, Pier Luigi; Donati, Davide Maria; Picci, Piero; Ferrari, Stefano; Scotlandi, Katia | 2018-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression | Marino, M.T.; Grilli, A.; Baricordi, C.; Manara, M.C.; Ventura, S.; Pinca, R.S.; Bellenghi, M.; C...alvaruso, M.; Mattia, G.; Donati, D.; Tripodo, C.; Picci, P.; Ferrari, S.; Scotlandi, K. | 2014-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy | Nakatani F.; Ferracin M.; Manara M.C.; Ventura S.; del Monaco V.; Ferrari S.; Alberghini M.; Gril...li A.; Knuutila S.; Schaefer K.L.; Mattia G.; Negrini M.; Picci P.; Serra M.; Scotlandi K. | 2012-01-01 | JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| NVE-BEZ235 as a new therapeutic option for sarcomas. | M.C. Manara; G. Nicoletti; D. Zambelli; S. Ventura; C. Guerzoni; L. Landuzzi; P.-L. Lollini; S.-M.... Maira; C. Garcia-Echeverria; M. Mercuri; P. Picci; K. Scotlandi | 2010-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |